What Is Basal and Bolus Insulin Therapy?

When the pancreas does not produce enough insulin, basal-bolus therapy can help manage diabetes. This treatment combination can help release the right amount of insulin to prevent spikes, mimicking what a healthy pancreas can do.
Basal vs. Bolus: What They Are
According to the CDC, there are seven types of insulin, and they vary based on the onset, peak time, and duration.
-
- Rapid-acting: Works in 15 minutes and peaks in 1 hour
- Rapid-acting inhaled: Works in 10 to 15 minutes and peaks in 30 minutes
- Regular- or short-acting: Takes effect in 30 minutes and peaks in 2 to 3 hours
- Intermediate-acting: Works in 2 to 4 hours and peaks in 4 to 12 hours
- Long-acting: Takes effect in 2 hours and doesn’t peak
- Ultra-long acting: Works in 6 hours and doesn’t peak
- Premixed: Works in 5 to 60 minutes with peaks that vary
Rapid-acting and short-acting insulins are considered bolus insulins. They provide bursts of insulin after meals to prevent spikes. Intermediate-, long-, and ultra-long-acting insulins are basal types that begin working about 2 hours after injection and last for at least half a day.
Basal insulin is long-acting. You’ll hear others refer to it as the “background insulin” because it works behind the scenes. It delivers a steady but low amount of insulin throughout the day and night to stabilize blood sugar levels overnight or any time you’re not eating.
Bolus insulin is short- or rapid-acting. Doctors prescribe it to manage blood sugar spikes after meals. Because of its rapid onset, bolus insulin can start working within about 30 minutes of injection.
How They Work Together
Basal and bolus insulin replicate the natural pattern of insulin release in an individual without diabetes. The basal helps prevent large blood sugar swings while you’re not eating. Meanwhile, the bolus insulin kicks in after meals to manage glucose surges.
Why It’s Often Prescribed for Type 1
Doctors recommend basal-bolus insulin therapy for people with type 1 diabetes, since their pancreas produces little to no insulin. The basal-bolus insulin therapy is used to reduce complications tied to fluctuating blood sugar levels.
Basal vs. Bolus Insulin: What’s the Difference?
Here’s how basal and bolus insulin differ.
| Feature | Basal Insulin | Bolus Insulin |
|---|---|---|
| Purpose | Provides steady, background insulin to control blood sugar between meals and overnight | Covers blood sugar spikes from meals and corrects unexpected highs |
| Timing of Use | Given once or twice daily, regardless of meals | Taken before or sometimes immediately after meals; may also be used as a “correction dose” |
| Duration of Action | Long-acting (up to 24 to 42 hours, depending on type) | Rapid-acting (3 to 5 hours) or short-acting (6 to 8 hours) |
| How It Fits Into Therapy | Keeps fasting glucose in check | Controls post-meal glucose levels |
| Common Types | Glargine (Lantus, Toujeo, Basaglar), detemir (Levemir), degludec (Tresiba) | Rapid-acting: Lispro (Humalog), Aspart (NovoLog), Glulisine (Apidra). Short-acting: Regular insulin (Humulin R, Novolin R) |
| Monitoring Needs | Adjusted based on fasting blood sugar and sometimes overnight readings | Adjusted using carbohydrate counting, pre-meal glucose checks, and sliding scale or correction factors |
| Risk of Hypoglycemia | Lower, but possible if overdosed or meals are skipped | Higher if timing or dosing doesn’t match food intake or activity level |
| Examples of Use | Basal alone may be used in early type 2 diabetes or when fasting glucose is the main issue | Basal + bolus is typically required in type 1 diabetes and advanced type 2 when mealtime spikes become harder to manage |
Understanding Basal Insulin
Blood sugar levels can fluctuate during sleep, sometimes leading to high glucose levels upon waking. This can happen even in people with diabetes for reasons such as the dawn phenomenon and the Somogyi effect.
The role of basal insulin is to provide a steady supply of insulin throughout the day and night to keep your blood sugar stable while you sleep or during times when you’re not eating. Below are some examples of basal insulin.
-
- Insulin glargine: Sold under different brands, including Lantus, Basaglar, and Toujeo
- Insulin detemir: Sold under Levemir
- Insulin degludec: Sold under the brand name Tresiba
These long-acting insulins provide background coverage to manage blood sugar swings in people with diabetes.
What Is Bolus Insulin?
While long-acting insulin provides background coverage, bolus insulin works after meals, when blood sugar rises quickly, helping the body process glucose from carbohydrates. This effect helps correct and keep mealtime swings under control.
There are two main types of bolus insulin — rapid-acting and short-acting insulins. Below are some bolus insulin examples.
-
- Rapid-acting insulins: Includes insulin lispro, aspart, and glulisine. Common brands are Humalog, Admelog, NovoLog, Fiasp, and Apidra.
- Short-acting insulins: Includes regular human insulin. Common brands are Novolin R, Humulin-R, and Actrapid.
These insulins act quickly, so they are typically given shortly before meals. Dosage is calculated based on carb content, current glucose readings, or with the use of a sliding-scale plan. With practice and guidance, patients can use bolus insulin to keep mealtime swings under control and feel more confident managing their diabetes.
Examples of Basal-Bolus Insulin Regimens
If your doctor prescribes a basal bolus insulin regimen, you’ll inject two types of insulin. Here’s an example of the treatment regimen.
| Regimen | Basal Insulin | Bolus Insulin | Typical Use Case |
| Classic once-a-day basal + bolus with each meal | Long-acting insulin (e.g., glargine / Lantus or Tresiba) once daily (often at bedtime) | Rapid-acting insulin (e.g. Humalog / lispro, Novorapid / aspart, Fiasp) before each meal | Often used for people with type 1 diabetes or type 2, when mealtimes are relatively regular and predictable. Helps mimic natural insulin patterns. |
| Twice-daily basal + bolus | Split basal dosing (morning + evening) — sometimes with detemir or glargine, depending on duration | Rapid-acting insulin at meals; sometimes with correction doses | For people whose long-acting basal insulin doesn’t last a full 24 hours, or whose glucose rises overnight or late in day; gives more coverage. |
| Flexible or intensive basal-bolus with correction factor | Long-acting basal insulin at stable dose; adjusted occasionally based on overnight/fasting glucose trends | Bolus insulin doses that account for both (a) carbohydrates in the upcoming meal via “carbohydrate-to-insulin ratio,” and (b) “correction factor” when pre-meal glucose is above target. | Useful for people with variable meal sizes, irregular schedules, or using continuous glucose monitoring. Enables tighter control. |
Common Drug Pairings
Your doctor will carefully decide which basal and bolus insulins to pair to match your needs.
-
- Glargine (Lantus, Basaglar, or glargine U300 like Toujeo or Tresiba) paired with lispro (Humalog) or aspart (Novorapid or NovoLog)
- Some regimens may use Glargine + Fiasp (an ultra-fast acting bolus) for greater flexibility around variable meal times.
While your doctor recommends the initial pairing, it can be adjusted to suit your lifestyle, health goals, and the level of flexibility you want in the treatment.
Cost and Accessibility Considerations
Cost is the biggest challenge with basal-bolus insulin therapy. Injecting two types of insulin means you’ll have to purchase two medications. To determine the estimated costs, let’s use Lantus as the basal insulin and Humalog as the bolus pair. In the U.S., the average retail price of Lantus SoloStar pens for a month’s supply is $550, while Humalog KwikPens cost $598. As a result, monthly medication expenses can exceed $1,000.
Insurance coverage, access to savings programs, and coupons can help reduce your monthly costs. Medications in the U.S. are often expensive because of the lack of policies around drug price controls. By contrast, Canadian pharmacies offer the same prescriptions for up to 90% less, thanks to stricter drug price regulations.
Buy Canadian Insulin (BCI) is an online prescription platform that partners with licensed Canadian pharmacies to offer you up to 90% off savings on your antidiabetic medications. You can order five Lantus SoloStar pens for only $177 and five Humalog KwikPens U-100 for only $102. These prices are up to 80% less than their U.S. retail prices. Other basal-bolus insulin brands are also less expensive than buying them at local pharmacies. Consider ordering your prescriptions from BCI to save more on monthly prescriptions and afford long-term treatment.
Articles you may also be interested in
Basal-Bolus Insulin Calculator for Managing Therapy
There’s no standard dosage for basal-bolus insulin therapy. The dose is personalized, and the initial dose is calculated based on insulin-to-carb ratio, insulin sensitivity factor, and target blood sugar. Your basal-to-bolus ratio can change over time based on your needs.
While doctors determine the initial basal and bolus doses, you will be responsible for adjusting your own insulin doses. For many patients, basal doses are only adjusted when there’s a significant change in body weight, insulin sensitivity, or overall health. Meanwhile, bolus doses are more flexible and change based on carb intake, pre-meal glucose level, and exercise habits. People who are more physically active may need fewer units of basal insulin.
To easily manage insulin therapy, some patients use insulin calculators. These tools available in phone apps automatically calculate the units of insulin you should inject. However, you should not rely on them, as studies show they can provide inaccurate dosing recommendations.
In an earlier study, 67% of the 46 medical apps reviewed by experts had the potential to suggest incorrect insulin doses, which could be unsafe for patients. Exercise caution when using an insulin calculator app and always confirm if your dose is correct.
Benefits and Challenges of Basal-Bolus Therapy
One of the main benefits of basal-bolus insulin therapy is improved glycemic control. People call it the “gold standard” treatment because it closely mimics how a healthy pancreas works, with basal insulin providing a steady background coverage and bolus doses covering meals.
However, the downside of the basal-bolus plan is the use of an insulin pump or the daily injections required, which can be overwhelming for some people. If the timing or dose isn’t correct, the risk of hypoglycemia is high. Moreover, you’ll have to learn how to count the carbs and adjust the doses appropriately. For this reason, you’ll need to work with your doctor until you feel confident adjusting your dose independently.
Who Should Not Use Basal-Bolus Therapy
Doctors often recommend the basal-bolus insulin therapy for people with type 1 diabetes, advanced type 2 diabetes, and women with gestational diabetes.
Since the basal-bolus insulin therapy requires multiple daily injections, it may not be suitable for the following types of patients:
-
- People with cognitive impairment who struggle with remembering doses
- Individuals with a high risk of severe hypoglycemia, such as older adults
- Those without a fixed meal schedule
If you prefer a simpler routine with fewer injections, ask your doctor about alternative options.
Combining Basal and Bolus Insulin Therapy for Diabetes
Basal insulin is long-acting insulin that provides blood sugar coverage between meals and overnight. In contrast, bolus insulin is rapid- or short-acting and prevents spikes after meals.
The combination of basal-bolus insulin therapy closely imitates the way the pancreas works in regulating blood sugar levels, making it the gold standard treatment for people with type 1 diabetes and those with advanced type 2 diabetes. The downside is the need for multiple injections, pump management, and frequent monitoring, which many patients find overwhelming.
You can manage the treatment by working closely with your doctor until the treatment regimen becomes an easy part of your day-to-day routine.
Frequently Asked Questions
Original Publish Date: 6/04/2021 – Updated 9/19/2025




